HERG Screening Market Size, Share, and Analysis, By Type (Gene KCNH2, Mutant KCNH2, and Others), By Ion Channel (Voltage Gated, Ligand Gated, and Others), By Application (Antiarrhythmic, Antipsychotic, Antibiotic, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
HERG Screening Market Size, Share, and Analysis, By Type (Gene KCNH2, Mutant KCNH2, and Others), By Ion Channel (Voltage Gated, Ligand Gated, and Others), By Application (Antiarrhythmic, Antipsychotic, Antibiotic, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034
PRODUCT OVERVIEW
HERG Screening Market is anticipated t%li%exhibit a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast span from 2024 t%li%2034. In 2023, the market size was assessed at USD 1.7 billion and is projected t%li%reach USD 7.1 billion by the completion of 2034.
HERG screening refers t%li%an essential component in drug development, which serves t%li%evaluate the cardiotoxicity of a compound. The HERG gene includes a potassium ion channel which is crucial for regulating cardiac electrical activity. Certain drugs have the potential t%li%cause fatal ventricular arrhythmias by blocking HERG channels, which causes longer QT intervals on ECGs. HERG screening is an active measure that involves the systematic testing of compounds t%li%assess their impact on HERG channels. This process helps in early identification and elimination of drugs with potential proarrhythmic effects and ensures a safer pharmaceutical development pathway. Consequently, by identifying and reducing the risks associated with HERG inhibition, this screening method contribute in the well-being of patient and minimize cardiovascular complications related t%li%drug usage.
MARKET HIGHLIGHTS
HERG Screening Market is projected t%li%reach USD 7.1 billion over the forecast period, owing t%li%the rising focus on drug safety within the pharmaceutical development sector. The increasing awareness of potential cardiotoxicity risks that are associated with drug compounds is promoting the demand for HERG screening services and technologies. This surge is attributed t%li%the persistent endeavours by pharmaceutical industries t%li%improve drug development methods and adhere t%li%regulatory standards. Additionally, technological innovations in high-throughput screening and automation are significant contributors, which facilitate the effective assessment of compound libraries. Moreover, frequent collaborations between pharmaceutical companies and contract research organizations highlights a strategic change towards outsourcing HERG screening services. This development indicates of a wider industry strategy t%li%improve efficiency while maintaining strict safety protocols. Thus, as the global pharmaceutical ecosystem continues its expansion, HERG screening market will assume an important role in ensuring the safety and efficacy of emerging drug candidates, thereby presenting attractive opportunities for stakeholders in this sector.
HERG Screening Market Segments:
Growth Drivers
Improvements in Technology will Generate Growth Opportunities
Increased Focus on Drug Safety will Lead t%li%Market Expansion
Restraint
Industry Growth Could be Hampered by Cost and Resource Intensiveness
Key Players
PRODUCT OVERVIEW
HERG Screening Market is anticipated t%li%exhibit a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast span from 2024 t%li%2034. In 2023, the market size was assessed at USD 1.7 billion and is projected t%li%reach USD 7.1 billion by the completion of 2034.
HERG screening refers t%li%an essential component in drug development, which serves t%li%evaluate the cardiotoxicity of a compound. The HERG gene includes a potassium ion channel which is crucial for regulating cardiac electrical activity. Certain drugs have the potential t%li%cause fatal ventricular arrhythmias by blocking HERG channels, which causes longer QT intervals on ECGs. HERG screening is an active measure that involves the systematic testing of compounds t%li%assess their impact on HERG channels. This process helps in early identification and elimination of drugs with potential proarrhythmic effects and ensures a safer pharmaceutical development pathway. Consequently, by identifying and reducing the risks associated with HERG inhibition, this screening method contribute in the well-being of patient and minimize cardiovascular complications related t%li%drug usage.
MARKET HIGHLIGHTS
HERG Screening Market is projected t%li%reach USD 7.1 billion over the forecast period, owing t%li%the rising focus on drug safety within the pharmaceutical development sector. The increasing awareness of potential cardiotoxicity risks that are associated with drug compounds is promoting the demand for HERG screening services and technologies. This surge is attributed t%li%the persistent endeavours by pharmaceutical industries t%li%improve drug development methods and adhere t%li%regulatory standards. Additionally, technological innovations in high-throughput screening and automation are significant contributors, which facilitate the effective assessment of compound libraries. Moreover, frequent collaborations between pharmaceutical companies and contract research organizations highlights a strategic change towards outsourcing HERG screening services. This development indicates of a wider industry strategy t%li%improve efficiency while maintaining strict safety protocols. Thus, as the global pharmaceutical ecosystem continues its expansion, HERG screening market will assume an important role in ensuring the safety and efficacy of emerging drug candidates, thereby presenting attractive opportunities for stakeholders in this sector.
HERG Screening Market Segments:
- By Type
- Gene KCNH2
- Mutant KCNH2
- Others
- By Ion-Channel
- Voltage Gated
- Ligand Gated
- Others
- By Application
- Antiarrhythmic
- Antipsychotic
- Antibiotic
- Others
Growth Drivers
Improvements in Technology will Generate Growth Opportunities
Increased Focus on Drug Safety will Lead t%li%Market Expansion
Restraint
Industry Growth Could be Hampered by Cost and Resource Intensiveness
Key Players
- Charles River Laboratories International, Inc.
- Therm%li%Fisher Scientific Inc.
- Molecular Devices, LLC
- Eurofins Discovery
- Nanion Technologies GmbH
- QPS Holdings, LLC
- SB Drug Discovery
- Sophion Bioscience A/S
- ChanTest Corporation
- Cyprotex
- Evotec SE
- Apredica
- Shanghai Medicilon Inc.
- B'SYS GmbH
- Acea Biosciences, Inc.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3.HERG Screening Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.HERG Screening Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HERG SCREENING MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. HERG SCREENING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1. Gene KCNH2
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Mutant KCNH2
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Others
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Ion-Channel
11.3.2.1.Voltage Gated
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Ligand Gated
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By Application
11.3.3.1.Antiarrhythmic
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Antipsychotic
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Antibiotics
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2.By Ion-Channel
12.3.3.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2.By Ion-Channel
13.3.3.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2.By Ion-Channel
14.3.3.By Application
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2.By Ion-Channel
15.3.3.By Application
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2.By Ion-Channel
16.3.3.By Application
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Charles River Laboratories International, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Thermo Fisher Scientific Inc.
18.3.Molecular Devices, LLC
18.4. Eurofins Discovery
18.5.Nanion Technologies GmbH
18.6.QPS Holdings, LLC
18.7.SB Drug Discovery
18.8. Sophion Bioscience A/S
18.9.ChanTest Corporation
18.10. Cyprotex
18.11. Evotec SE
18.12. Apredica
18.13. Shanghai Medicilon Inc.
18.14. B'SYS GmbH
18.15. Acea Biosciences, Inc.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3.HERG Screening Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.HERG Screening Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. HERG SCREENING MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. HERG SCREENING MARKET
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1. Gene KCNH2
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Mutant KCNH2
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Others
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Ion-Channel
11.3.2.1.Voltage Gated
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Ligand Gated
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By Application
11.3.3.1.Antiarrhythmic
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Antipsychotic
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Antibiotics
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2.Market Share (%) 2024-2034F
11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
12. NORTH AMERICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Type
12.3.2.By Ion-Channel
12.3.3.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Type
13.3.2.By Ion-Channel
13.3.3.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Type
14.3.2.By Ion-Channel
14.3.3.By Application
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Type
15.3.2.By Ion-Channel
15.3.3.By Application
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA HERG SCREENING MARKET SIZE & FORECAST 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Type
16.3.2.By Ion-Channel
16.3.3.By Application
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Charles River Laboratories International, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Thermo Fisher Scientific Inc.
18.3.Molecular Devices, LLC
18.4. Eurofins Discovery
18.5.Nanion Technologies GmbH
18.6.QPS Holdings, LLC
18.7.SB Drug Discovery
18.8. Sophion Bioscience A/S
18.9.ChanTest Corporation
18.10. Cyprotex
18.11. Evotec SE
18.12. Apredica
18.13. Shanghai Medicilon Inc.
18.14. B'SYS GmbH
18.15. Acea Biosciences, Inc.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
